We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Case of Epstein-Barr Virus-associated T/B Cell Lymphoproliferative Disease Successfully Treated with Rituximab, Cyclophosphamide, Vindesine and Prednisone.
- Authors
Qian, L.; Shen, J.; Cen, J.
- Abstract
Epstein-Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) cover a wide range of lymphocytes disorders spanning B, T and natural killer cells. The classification of EBV-associated LPD is evolving. We report a case of a 63-year-old male patient with EBV-associated T/B cell LPD diagnosed by pathological biopsy of lymph nodes, which is a new type of EBVassociated LPD that has not been reported previously. Because of its rarity, standard treatment has not been established. This patient showed rapid remission of the disease after combination chemotherapy with rituximab, which provided evidence supporting the use of rituximab and chemotherapy combination in EBV-associated T/B cell LPD treatment.
- Subjects
LYMPHOPROLIFERATIVE disorders; B cells; TREATMENT effectiveness; KILLER cells; CYTOTOXIC T cells
- Publication
West Indian Medical Journal, 2021, Vol 69, Issue 6, p444
- ISSN
0043-3144
- Publication type
Article
- DOI
10.7727/wiimj.2016.209